PATIENTS CAN'T WAIT. NEITHER CAN WE. Trademark

Trademark Overview


On Wednesday, July 22, 2020, a trademark application was filed for PATIENTS CAN'T WAIT. NEITHER CAN WE. with the United States Patent and Trademark Office. The USPTO has given the PATIENTS CAN'T WAIT. NEITHER CAN WE. trademark a serial number of 90066400. The federal status of this trademark filing is REGISTERED as of Tuesday, June 25, 2024. This trademark is owned by Covance, Inc.. The PATIENTS CAN'T WAIT. NEITHER CAN WE. trademark is filed in the Computer & Software Services & Scientific Services and Medical & Beauty Services & Agricultural Services categories with the following description:

Medical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; medical testing for diagnostic, treatment, or screening purposes; medical testing for forensic purposes; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care and healthcare; medical consulting in the field of patient management and outcomes; providing an online computer database in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing an online computer database featuring medical information in the field of patient ma...

Scientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarker...
patients can't wait. neither can we.

General Information


Serial Number90066400
Word MarkPATIENTS CAN'T WAIT. NEITHER CAN WE.
Filing DateWednesday, July 22, 2020
Status700 - REGISTERED
Status DateTuesday, June 25, 2024
Registration Number7429611
Registration DateTuesday, June 25, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, December 22, 2020

Trademark Statements


Goods and ServicesMedical services in the fields of pathology, pharmacology, and immunology; medical and psychological counseling; medical testing for diagnostic, treatment, or screening purposes; medical testing for forensic purposes; genetic testing for medical purposes; medical testing for diagnostic and treatment purposes; consulting services in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care and healthcare; medical consulting in the field of patient management and outcomes; providing an online computer database in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing an online computer database featuring medical information in the field of patient management and outcomes; providing a website featuring information in the fields of medical testing, testing for medical forensic purposes, genetic testing for medical purposes and relating to diagnostic, prophylactic and therapeutic information in the fields of disease, medical care, and healthcare; providing a website featuring medical information in the field of patient management and outcomes
Goods and ServicesScientific research and development; pharmaceutical drug development and testing services; research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; medical and scientific research, namely, designing, organizing, conducting, monitoring, and managing clinical and non-clinical trials and studies on pharmaceuticals and medical devices for others; scientific consulting services for others in the field of clinical and non-clinical trials and studies on pharmaceuticals and medical devices; collection, calibration, analysis and reporting of medical and scientific research data in connection with clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific laboratory services; scientific laboratory services, namely, formulating and bioprocessing pharmaceuticals; operating and maintaining a biorepository for medical and scientific research purposes; scientific research and analysis in the fields of bioinformatics, biomarkers, genomics, proteomics, genotyping, and genetic profiling; custom design and development of chemical reagents and biochemical assays; medical laboratory services in the field of pathology; computer hardware and software design; design and development of software for use in conducting biological research in non-clinical pharmaceutical and medical device and development studies; providing online computer databases in the fields of research and development of pharmaceuticals, medical devices, biotechnology, and biochemicals; data mining; providing a website featuring technology enabling users to remotely track, monitor, analyze, and generate reports with information and statistics from clinical and non-clinical trials and studies on pharmaceuticals and medical devices; scientific research and analysis in the field of pharmacology; advisory services in the field of pharmaceutical drug development, namely, selecting biological research models for use in testing drugs; advisory services in the field of pharmaceutical drug development, namely, selecting biomarkers for use in testing drugs; lead candidate drug optimization services, namely, scientific research in the field of identifying compounds for drug development; providing medical and scientific information in the fields of biochemistry, pharmaceuticals and clinical trials; acting as an application service provider featuring software for use in database and record management in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing non-downloadable software through a web-based portal to collect, organize, and report medical information, medical records, and diagnostic testing records; providing a web-based portal in the fields of medical testing for scientific research purposes, testing for forensic research purposes, testing for quality control purposes, genetic testing for scientific research purposes, and medical and scientific research in the field of, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; providing temporary use of online non-downloadable software for storing, retrieving, accessing, displaying, managing, analyzing, and reviewing information and data in the fields of medical testing, testing for forensic purposes, testing for quality control purposes, genetic testing, clinical and analytical testing, disease, medical care, healthcare, pharmaceuticals, medical devices, biochemicals, and biotechnology; electronic storage of data; consulting services in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing an online computer database in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; providing a website featuring information in the fields of testing for drug, alcohol and DNA screening for forensic research purposes and testing for quality control purposes; medical testing for quality control purposes

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 19, 2020
Primary Code042
First Use Anywhere DateThursday, August 31, 2023
First Use In Commerce DateThursday, August 31, 2023

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, August 19, 2020
Primary Code044
First Use Anywhere DateThursday, August 31, 2023
First Use In Commerce DateThursday, August 31, 2023

Trademark Owner History


Party NameLABCORP DRUG DEVELOPMENT INC.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressPRINCETON, NJ 08540-6233

Party NameLABCORP DRUG DEVELOPMENT INC.
Party Type21 - New Owner After Publication
Legal Entity Type03 - Corporation
AddressPRINCETON, NJ 08540-6233

Party NameCovance, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 085406233

Party NameCovance, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPrinceton, NJ 085406233

Trademark Events


Event DateEvent Description
Saturday, July 25, 2020NEW APPLICATION ENTERED
Wednesday, August 19, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, November 6, 2020ASSIGNED TO EXAMINER
Tuesday, November 17, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 2, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, December 22, 2020PUBLISHED FOR OPPOSITION
Tuesday, December 22, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, February 16, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Monday, August 16, 2021SOU TEAS EXTENSION RECEIVED
Monday, August 16, 2021SOU EXTENSION 1 FILED
Monday, August 16, 2021SOU EXTENSION 1 GRANTED
Wednesday, August 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 16, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, February 16, 2022SOU EXTENSION 2 FILED
Wednesday, February 16, 2022SOU EXTENSION 2 GRANTED
Friday, February 18, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, August 15, 2022SOU TEAS EXTENSION RECEIVED
Monday, August 15, 2022SOU EXTENSION 3 FILED
Monday, August 15, 2022SOU EXTENSION 3 GRANTED
Wednesday, August 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, September 7, 2022AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Thursday, February 16, 2023SOU TEAS EXTENSION RECEIVED
Thursday, February 16, 2023TEAS REQUEST TO DIVIDE RECEIVED
Thursday, February 16, 2023DIVISIONAL REQUEST RECEIVED
Thursday, February 16, 2023SOU EXTENSION 4 FILED
Monday, March 13, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, April 25, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, May 30, 2023DIVISIONAL PROCESSING COMPLETE
Tuesday, May 30, 2023SOU EXTENSION 4 GRANTED
Tuesday, August 15, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, May 31, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Saturday, June 24, 2023CORRECTED NOA E-MAILED
Tuesday, August 15, 2023SOU EXTENSION 5 FILED
Thursday, August 24, 2023SOU EXTENSION 5 GRANTED
Thursday, May 16, 2024ASSIGNED TO EXAMINER
Thursday, May 23, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Thursday, May 23, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, August 25, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, February 15, 2024USE AMENDMENT FILED
Thursday, February 22, 2024STATEMENT OF USE PROCESSING COMPLETE
Thursday, February 15, 2024TEAS STATEMENT OF USE RECEIVED
Tuesday, June 25, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, June 25, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED